Clinical Summary on Prevantics® Skin & Device Use To Reduce Blood Culture Contamination
The abstract, which was presented at the American Society for Clinical Laboratory Science (ASCLS) and the Association of Genetic Technologists (AGT) Joint Annual 2020 Virtual Meeting by Sutton R, Sanderson J, Taylor L, Nash UNC Healthcare, examines blood culture contamination. False-positive blood cultures may lead to increased clinical and financial burdens for patients. The goal of this project was to reduce and sustain blood culture contamination rates below the national benchmark (<3%). Our facility began a staggered interventional approach using education of staff along with direct draw method of blood culture collection, a trial of new product (3.15% CHG/ 70% IPA) on both skin and tops of blood culture bottles for 1 month, a 6-month period of original products, and final implementation of new product hospital-wide.